Q3FY22 Earnings: Godrej Properties, Kirloskar Industries, Kalyan Jewellers, Cadila Health and Triveni Engineering announced December quarter results - key highlights!

Several listed companies announced their December quarter results on Thursday. Some important results that were announced today were Godrej Properties Limited, Kirloskar Industries Limited, Kalyan Jewellers Limited, Cadila Healthcare Limited and Triveni Engineering & Industries Limited. Some of the key highlights of the results declared by these companies are as under:  

Godrej Properties logs nearly three-fold jump in Q3 profit at Rs 39 cr

Godrej Properties on Thursday said its consolidated net profit in December quarter nearly tripled to Rs 38.95 crore.

See Zee Business Live TV Streaming Below:

Its net profit stood at Rs 14.35 crore in the same period of 2020-21.

Total income increased to Rs 466.91 crore in the quarter from Rs 311.12 crore in the corresponding period of the previous year, according to a regulatory filing.

Net profit jumped multi-fold to Rs 91.68 crore during the first nine months of 2021-22 from Rs 2.19 crore in the year-ago period.

Total income rose to Rs 1,063.12 crore during April-December period of this fiscal year from Rs 757.01 crore a year ago.

Mumbai-based Godrej Properties is one of the leading real estate developers in India. It has a major presence in Mumbai region, Pune, Delhi-NCR and Bengaluru. 

Kirloskar Industries Q3 net drops 28% to Rs 85 cr

Kirloskar Industries Ltd on Thursday reported a 28.48 per cent decline in consolidated net profit from continuing operations at Rs 84.64 crore for the third quarter ended December 2021, hampered by higher expenses.
The company had posted a consolidated net profit from continuing operations of Rs 118.35 crore in the same period last fiscal, Kirloskar Industries said in a regulatory filing.
Consolidated total revenue from operations stood at Rs 935.75 crore as compared to Rs 591.63 crore in the year-ago quarter.
Total expenses were higher at Rs 829.83 crore in the third quarter as compared to Rs 477.62 crore earlier, the company said.
Kirloskar Industries said its iron casting vertical posted revenue of Rs 933.68 crore in the third quarter, as against Rs 590.66 crore in the same period a year ago.
Wind power generation segment had a revenue of Rs 76 lakh, compared to Rs 42 lakh earlier. PTI RKL
ABM

Kalyan Jewellers Q3 consolidated PAT up 16% at Rs 134 cr

Kalyan Jewellers India on Thursday reported a 16.48 per cent rise in its consolidated profit after tax (PAT) at Rs 134.52 crore for the quarter ended December 2021.

The jewellery retailer's PAT stood at Rs 115.48 crore during the corresponding quarter of 2020-21, Kalyan Jewellers said in an exchange filing.

Revenue from operations grew by 16.99 per cent to Rs 3,435.39 crore, compared to Rs 2,936.25 crore in the same period of the previous fiscal.

There were certain one-time expenses comprising showroom write-offs due to relocation and a one-time bonus to employees totalling Rs 8 crore.

Normalising this, the standalone India EBITDA growth would have been 5 per cent, it added.

The company further said in the Middle East it witnessed a significant improvement in customer sentiment during the quarter, resulting in revenue growth of 24 per cent on an annual basis.

Total revenue from the Middle East operations during the third quarter of this fiscal was at Rs 515 crore, as against Rs 417 crore in the year-ago period.

For the first time since the onset of COVID-19, the majority of its showrooms in the region have recorded revenue higher than the pre-pandemic levels, the company noted.

The e-commerce division of the company, Candere, continued its growth momentum at Rs 47 crore versus Rs 34 crore in the third quarter FY21, a jump of 40 per cent.

Presently, the company's retail footprint is spread across 151 stores in 21 Indian states and 4 countries in the Middle East.

"The overall third quarter performance of the company has been very satisfying, with strong momentum in revenue and footfalls across geographies. At the start of this quarter, we have witnessed Covid induced weekend lockdowns leading to showroom closures, in some regions.

"We are also seeing weddings and celebrations being postponed," Kalyan Jewellers India Executive Director Ramesh Kalyanaraman said.

However, due to its resilient nature, Kalyan Jewellers is expecting demand to bounce back in the subsequent quarters, like it was witnessed in the previous year, he added. PTI

Cadila Healthcare posts 5% decline in net profit at 500 cr in Q3

Cadila Healthcare Ltd on Thursday reported a 5 per cent decline in consolidated net profit at Rs 500.4 crore in the third quarter ended December 31, 2021.

The company had posted a consolidated net profit of Rs 527.2 crore in the same period last fiscal, Cadila Healthcare said in a regulatory filing.

Consolidated total revenue from operations stood at Rs 3,655 crore during the quarter under review as compared to Rs 3,633 crore in the year-ago quarter, it added.

Total expenses were higher at Rs 3,116.8 crore in the third quarter as compared to Rs 3,069.8 crore in the year-ago period, Cadila Healthcare said.

India formulations business posted revenue of Rs 1,079 crore during the third quarter with branded formulations posting a 17 per cent growth after adjusting for sales of COVID related products, generics portfolio and divested products, the company said.

On the other hand, the US formulations business registered revenue of Rs 1,504 crore during the quarter and the company filed 12 additional abbreviated new drug applications (ANDAs) with the USFDA.

It received nine new product approvals, including five tentative approvals, from the USFDA, the company said, adding it launched three new products in the US market.

These include Nelarabine injection used to treat certain types of leukemia and lymphoma, which was granted 180 days exclusivity.

Cadila Healthcare said the group has also started supplies of its COVID-19 vaccine ZyCoV-D, to the government of India against their order from its newly commissioned Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Ahmedabad.

The group is also planning to make the vaccine available in the private market. ZyCoV-D is a three dose vaccine administered intradermally using the PharmaJet needle free system, Tropis, on day 0, day 28 and day 56, it added.

The company further said it has also submitted the New Drug Application (NDA) to the DCGI for Desidustat, for the treatment of anaemia in patients with chronic kidney disease (CKD). PTI RKL

Triveni Engineering Q3 profit rises 37 pc to Rs 130 cr; revenue up at Rs 1,242 cr

Triveni Engineering and Industries Ltd (TEIL) has reported a 37 per cent rise in its consolidated net profit to Rs 130.12 crore for the December 2021 quarter on higher revenue.

The net profit of the company, which is into sugar and engineering businesses, stood at Rs 94.66 crore in the year-ago period.

The total income also increased to Rs 1,242.40 crore in the third quarter of this fiscal from Rs 1,130.73 crore in the corresponding period of the previous year, according to a regulatory filing.

It has an order book of Rs 1,808.39 crore for combined engineering businesses. The company's consolidated debt stood at Rs 592 crore as of December 31, 2021.

In a statement, TEIL's CMD Dhruv M Sawhney said: ?The increase in cane prices by Rs 250 per tonne for the sugar Season 2021-22 will be largely offset by the recent increase in sugar prices".

The estimated stocks of 6.65 million tonnes at the end of the current sugar season in September are likely to support the domestic sugar prices, he added.

Sawhney said the continuance of exports and/or substantial diversion of sugar for ethanol will be key to maintaining the sugar prices.

"We hope that the Government addresses the long-pending increase in Minimum Selling Price (MSP) of sugar to maintain the viability of sugar mills and to preserve their cane price paying capacity," he said.

On the pricing side, even though sugar prices have come off their recent peaks both in domestic and global markets, they are higher than last year.

With a global deficit anticipated yet again in the 2021-22 season, he expects international sugar prices to stay firm.

Without export assistance, Sawhney said, northern millers might not participate in exports unless the international prices improve meaningfully from current levels.

However, he said, exports might continue to be viable from Maharashtra and other coastal regions.

"The distillery segment continued its strong performance driven by higher sales volumes and realisation prices due to improved product mix," he said.

Sawhney said the company expects the first tranche of 220-kilo litre per day (KLPD) distillery expansion of its 340 KLPD growth plans to commence by March 2022.

The balance of 120 KLPD is expected to be operational around Q1 of FY23.

"The company's overall capacity after both expansions will more than double from current levels of 320 KLPD to 660 KLPD," he said.

Sawhney said the engineering businesses have largely overcome the impact of COVID on their operations and those of customers and has put up a much better performance in terms of turnover and profitability.

"A broad-based economic recovery, which is already underway, is likely to keep the demand strong for these businesses," he said.

Sawhney said the power transmission business was poised for strong growth in the coming years across the gamut of services, such as defence, gears and built to print.

"The company has a strong order pipeline in its water business and we continue to bid for many new projects to improve it further," he said.

TEIL is a diversified industrial conglomerate having a major presence in sugar and engineering.

It currently has seven sugar mills in Uttar Pradesh.

While the company's power transmission (Gears) manufacturing facility is located at Mysuru, the water and wastewater treatment business is in Noida.

The company currently operates 6 co-generation power plants located across five sugar units and two molasses-based distilleries in Uttar Pradesh, located at Muzaffarnagar and Sabitgarh.

The company manufactures Indian Made Indian Liquor (IMIL) at its Muzaffarnagar distillery.